What if you'd held ENTA?
A $1,000 investment in Enanta Pharmaceuticals, Inc. (ENTA) at the month-end close of 2013-03 would be worth $774 at the close of 2026-09 — -22.6% total return, dividends reinvested. The same $1,000 in the S&P 500, dividends reinvested, would be worth $6,245.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-09, dividends included.
Every year, $1,000 from 2013
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2013 | $1,000 | — |
| 2014 | $1,864 | +86.4% |
| 2015 | $1,210 | -35.1% |
| 2016 | $1,228 | +1.5% |
| 2017 | $2,151 | +75.2% |
| 2018 | $2,596 | +20.7% |
| 2019 | $2,265 | -12.8% |
| 2020 | $1,543 | -31.9% |
| 2021 | $2,741 | +77.6% |
| 2022 | $1,705 | -37.8% |
| 2023 | $345 | -79.8% |
| 2024 | $211 | -38.9% |
| 2025 | $578 | +174.3% |
| 2026 | $516 | -10.7% |
Best and worst month-end to buy
The best single month-end close to have bought ENTA was 2025-01 ($5.11): $1,000 then is $2,755 today. The worst was 2018-06 ($116): $1,000 then is $121.
FAQ
What would $1,000 in ENTA be worth today?
A $1,000 investment in Enanta Pharmaceuticals, Inc. (ENTA) at the start of 2013 would be worth about $774 today, a total return of -22.6%. Dividends are reinvested in these figures.
What were the best and worst years for ENTA?
Enanta Pharmaceuticals, Inc. (ENTA)'s strongest calendar year since 2013 was 2025, a +174.3% return — $1,000 held through that year became about $2,743 by year-end. Its weakest year was 2023, at -79.8%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in ENTA have grown?
Investing $100 at the end of every month since 2013-03 would have grown to about $9,667 on $16,300 invested.
Did ENTA beat the S&P 500?
Over the same period, $1,000 in the S&P 500 with dividends reinvested (the S&P 500 Total Return index) would be worth $6,245. ENTA trailed the S&P 500 by +87.6% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
Enanta Pharmaceuticals, Inc. (ENTA) historical total-return data from 2013-03 to 2026-09, reduced to month-end closes for the tables above.
Returns use adjusted close prices — adjusted for stock splits and reinvested dividends, the same convention used by major brokerages. End-of-day and live prices come from EODHD; parts of the deep historical series are carried over from Yahoo Finance data. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (EODHD): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via EODHD and Yahoo Finance. As of 2026-09-04. Not financial advice.